Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institutul De Cercetari Chimico-FarmaceuticefiledCriticalInstitutul De Cercetari Chimico-Farmaceutice
Priority to RO107523ApriorityCriticalpatent/RO83935B1/ro
Publication of RO83935A2publicationCriticalpatent/RO83935A2/ro
Publication of RO83935B1publicationCriticalpatent/RO83935B1/ro
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Unguentul hidrofil pe baza de colagen pentru tratamentul vulvo-vaginitelor distrofice este constituit din 5...20 g% hidrolizat de colagen, 0,015....0,030% hexoestrol diacetat, 0,080....0,150 g% hidrocortizon acetat, 6...8 g% anestezina, 50000 - 70000 u.i. vitamina A, înglobate într-o baza de unguent hidrofila, constituita din 18% alcool cetilix, 20% vaselina, 10% glicerina si 7,5% Tween 80.
RO107523A1982-05-141982-05-14Unguent hidrofil pe baza de colagen pentru tratamentul vulvo-vaginitelor distrofice
RO83935B1
(ro)